ROBERT WILLIAMS: Open Payments
NPI 1982635173 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 40 payments from 16 companies in 2025. Trend: 2023 $1,627 · 2024 $1,454 · 2025 $2,142
Food & beverage: $2,142
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $362 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $246 |
| AstraZeneca Pharmaceuticals LP | 3 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $190 |
| ABBVIE INC. | 4 | $187 |
| Stryker Corporation | 1 | $168 |
| GlaxoSmithKline, LLC. | 5 | $136 |
| Lundbeck LLC | 1 | $113 |
| C2N Diagnostics, LLC | 1 | $107 |
| TG Therapeutics, Inc. | 1 | $101 |
Products named: Ozempic, Kerendia, INSPACE, JARDIANCE, OFEV, AREXVY, AIRSUPRA, VYEPTI.
Industry payments across FL — which companies pay providers there.
